Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 34

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 34
---
 the securities; |

| ● | any over-allotment options under which underwriters may purchase 
 additional securities from us;                                   |

| ● | the net proceeds from the sale of the securities |

| ● | any delayed delivery arrangements |

| ● | any underwriting discounts, commissions and other items constituting 
 underwriters’ compensation;                                          |

| ● | any public offering price; |

| ● | any discounts or concessions allowed or reallowed or paid 
 to dealers;                                               |

| ● | any commissions paid to agents; and |

| ● | any securities exchange or market on which the securities 
 may be listed.                                            |

Sale Through Underwriters or Dealers

Only underwriters named in
the prospectus supplement are underwriters of the securities offered by the prospectus supplement.

<div align='center'>10</div>

If underwriters are used in
the sale, the underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending
or repurchase agreements with us. The underwriters may resell the securities from time to time in one or more transactions, including
negotiated transactions. Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described
in this prospectus or otherwise), including other public or private transactions and short sales. Underwriters may offer securities to
the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting
as underwriters. Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase the securities
will be subject to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase
any of them. The underwriters may change from time to time any public offering price and any discounts or concessions allowed or reallowed
or paid to dealers.

If dealers are used in the
sale of securities offered through this prospectus, we will sell the securities to them as principals. They may then resell those securities
to the public at varying prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the
dealers and the terms of the transaction.

Direct Sales and Sales Through Agents

We may sell the securities
offered through this prospectus directly. In this case, no underwriters or agents would be involved. Such securities may also be sold
through agents designated from time to time. The prospectus supplement will name any agent involved in the offer